Skip to main content
Home ESG Stocks
Haemonetics Corporation (HAE) Stock Analysis & ESG Ratings
HAE

Haemonetics Corporation

Market overview

USD 101.95

Down−USD 1.12 (−1.09%) Day change

Open
USD 103.60
Previous close
USD 103.07
Day high
USD 104.16
Day low
USD 101.64
Volume
633,645
Market cap
USD 4,638,424,064

USD · Market data via Massive Stock Widgets · Last close · As of

Price chart · 1 Year
Haemonetics Corporation 1 Year price chartHaemonetics Corporation, nyse:HAE, 1 Year price chart in USD. Start USD 53.54, end USD 101.95, high USD 108.80, low USD 47.67, up.
Period1 YearFirst closeUSD 53.54Last closeUSD 101.95Maximum closeUSD 108.80Minimum closeUSD 47.67Period change+USD 48.41Period percentage change+90.42%Chart as ofSep 1, 2026, 1:30 PM GMT+0000
View Chart Data
Representative chart points — 24 of 251
Date and time Open High Low Close Volume
USD 54.50 USD 54.72 USD 53.25 USD 53.54 737,100
USD 50.48 USD 50.65 USD 47.38 USD 47.67 1,459,200
USD 49.72 USD 50.67 USD 49.24 USD 50.26 899,000
USD 49.58 USD 50.34 USD 49.00 USD 50.01 462,800
USD 74.00 USD 75.09 USD 73.04 USD 74.32 919,000
USD 81.16 USD 82.42 USD 80.92 USD 81.91 865,900
USD 80.77 USD 80.97 USD 79.53 USD 79.90 714,900
USD 81.60 USD 83.16 USD 81.43 USD 82.77 515,400
USD 69.80 USD 71.79 USD 69.80 USD 70.02 1,207,100
USD 65.19 USD 66.09 USD 59.04 USD 59.34 2,022,600
USD 62.06 USD 63.29 USD 61.64 USD 61.68 1,059,900
USD 63.98 USD 64.18 USD 61.58 USD 62.85 957,100
USD 57.11 USD 57.72 USD 55.12 USD 55.93 495,700
USD 58.33 USD 58.40 USD 56.65 USD 57.32 447,200
USD 59.71 USD 61.48 USD 59.53 USD 60.48 569,800
USD 52.75 USD 54.45 USD 52.13 USD 54.01 971,200
USD 67.04 USD 68.34 USD 65.75 USD 67.04 1,014,300
USD 79.78 USD 80.94 USD 77.02 USD 78.20 1,198,300
USD 74.58 USD 75.78 USD 72.34 USD 75.00 562,600
USD 75.07 USD 77.07 USD 74.45 USD 76.68 534,800
USD 84.58 USD 84.97 USD 83.48 USD 84.82 555,200
USD 90.61 USD 91.49 USD 89.82 USD 90.80 533,300
USD 109.24 USD 109.57 USD 107.00 USD 108.80 582,100
USD 103.60 USD 104.16 USD 101.64 USD 101.95 633,645

ESG & Sustainability Rating Breakdown

Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.

Audited Methodology

Coverage PendingThird-Party ESG Coverage Under Review

Formal published scorecards from MSCI ESG Research and Sustainalytics are not currently available for this ticker. The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.

Sustainability Strengths & Catalysts (Pros)

  • Product focus on blood and plasma collection and transfusion management supports critical healthcare infrastructure and patient care, aligning the business with essential public health services.
  • Haemonetics publishes corporate responsibility information and frames its purpose around advancing patient care and stakeholder trust, indicating institutional attention to ESG-related governance and stakeholder engagement.
  • The company’s diversified product portfolio across plasma, blood center and hospital segments can enhance operational resilience and reduce concentration-related supply risks for healthcare customers.

Material Risks & Governance Concerns (Cons)

  • Haemonetics operates in regulated medical-device and blood-plasma sectors where product safety, quality control and regulatory compliance failures could lead to material patient-safety incidents, recalls or litigation risk.
  • Manufacturing and global supply-chain operations for medical disposables and devices expose the company to environmental impacts (e.g., waste from single-use disposables) and to supply-chain labor and sourcing risks across multiple jurisdictions.

Company Profile & Business Model Overview

Financial & Valuation Fundamentals

Earnings Per Share (EPS)
$19.49
Dividend Yield
2.64%

Data Integrity & Methodology Disclosure

Market quotes may be delayed and each visible snapshot states its source and observation time. ESG evaluations aggregate published ratings from MSCI ESG Research and Sustainalytics with normalized industry peer adjustments. Learn more in our ESG Rating Methodology.